Matrix metalloproteinases, tissue inhibitors of metalloproteinases, and heart failure outcomes

Int J Cardiol. 2011 Sep 1;151(2):237-9. doi: 10.1016/j.ijcard.2011.06.048. Epub 2011 Jul 1.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Disease Progression
  • Female
  • Heart Failure* / enzymology
  • Heart Failure* / epidemiology
  • Heart Failure* / physiopathology
  • Humans
  • Male
  • Matrix Metalloproteinases / metabolism*
  • Middle Aged
  • Morbidity / trends
  • Prognosis
  • Survival Rate / trends
  • Tissue Inhibitor of Metalloproteinases / metabolism*
  • United States / epidemiology
  • Ventricular Remodeling / physiology*

Substances

  • Tissue Inhibitor of Metalloproteinases
  • Matrix Metalloproteinases